✦ LIBER ✦

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers

✍ Scribed by Baker, A. F.; Adab, K. N.; Raghunand, N.; Chow, H. H. S.; Stratton, S. P.; Squire, S. W.; Boice, M.; Pestano, L. A.; Kirkpatrick, D. L.; Dragovich, T.

Book ID: 121637888
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 426 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9846-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

99 POSTER Phase IB trial of PX-12 delive

99 POSTER Phase IB trial of PX-12 delivered as a 24-hr infusion in patients with advanced gastrointestinal malignancies

✍ T. Dragovich; D. Rensvold; S. Wood; L. Pestano; T. Hysyong; L. Kirpatrick 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A randomized phase II study of PX-12, an

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

✍ Ramesh K. Ramanathan; James Abbruzzese; Tomislav Dragovich; Lynn Kirkpatrick; Jo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 267 KB

Pharmacokinetics of BW12C and mitomycin

Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer

✍ Ian F. Dennis; Jonathan R. S. Ramsay; Paul Workman; Norman M. Bleehen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 560 KB

A phase II trial of interleukin-12 in pa

A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates: Eastern Cooperative Oncology Group study E1E96

✍ Scott Wadler; Donna Levy; Helen L Frederickson; Carla I Falkson; Yuexian Wang; E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 133 KB